Civil Rights
Movements, leaders, victories and the continuing fight for equality.
Explore the people, places, events, achievements, struggles and stories that shaped our journey.
Movements, leaders, victories and the continuing fight for equality.
Innovation, patents, science, technology and world-changing contributions.
Pioneers, champions, Negro Leagues, records, activism and excellence.
Meet the people whose lives, choices and achievements shaped the journey.
Black towns, communities, institutions and places where history happened.
Moments that changed communities, movements, institutions and the nation.
In 1968 Shirley Chisholm became the first Black woman elected to the United States Congress. In 1972 she launched a campaign for the Democratic presidential nomination, breaking another political barrier.
MORE →Reflects the personal views, recollections, and perspective of the author, Mike Davis.
This is a personal recollection on the Move fire on May 13, 1985
This article may contain excessive or inappropriate references to self-published sources. (August 2024) |
Gravity Gradient Technology Satellite (GGTS) | |
| Mission type | Gravity-gradient stabilization |
|---|---|
| Operator | United States Air Force |
| COSPAR ID | 1966-053A |
| SATCAT no. | 2207[1] |
| Spacecraft properties | |
| Launch mass | 47 kilograms (104 lb) |
| Start of mission | |
| Launch date | June 16, 1966 14:00:01 UTC |
| Rocket | Titan IIIC |
| Launch site | Cape Canaveral LC41 |
| Orbital parameters | |
| Reference system | Geocentric |
| Regime | Geosynchronous |
| Perigee altitude | 33,663 kilometers (20,917 mi) |
| Apogee altitude | 33,858 kilometers (21,038 mi) |
| Inclination | 4.2° |
| Period | 1,334.00 minutes[2] |
The Gravity Gradient Test Satellite was launched by the US Air Force from Cape Canaveral LC41 aboard a Titan IIIC rocket on June 16, 1966, at 14:00:01 UTC.[3] The satellite was launched along with seven IDCSP satellites, with which it shared a bus.[4] In contrast to the solar-powered IDCSP satellites, GGTS was battery powered.[4]
GGTS utilized the 26.4-pound (12.0 kg) Magnetically Anchored Gravity Systems (MACS), which consisted of two identical subsystem packages, each containing an extensible rod unit and a magnetically anchored spherical viscous damper.[5] The rod units had an extended length of 15.8 meters (52 ft),[5] and their 5-kilogram (11 lb) damper tip weights gave the satellite a symmetric dumbbell configuration.[5] The dampers were produced by General Electric and consisted of two concentric spheres separated by a viscous damping fluid.[5] The internal sphere contained a hollow cylindrical magnet which served to "anchor' the inner sphere to the Earth's magnetic field,[5] stabilizing the satellite over time.[4]
It had been hoped that within 60 days of launch, the satellite would reach a stabilization of ±8° on the x- and y-axis.[4] The results were compromised, as one of the dampers was magnetically contaminated.[4]
A follow-up GGTS mission was lost due to a launch vehicle failure on August 28, 1966.[4]
Source: Wikipedia. Article content is retrieved live through the MediaWiki API.
The Gravity Gradient Test Satellite was launched by the US Air Force from Cape Canaveral LC41 aboard a Titan IIIC rocket on June 16, 1966, at 14:00:01 UTC. The satellite was launched along with seven IDCSP satellites, with which it shared a bus. In contrast to the solar-powered IDCSP satellites, GGTS was battery powered. GGTS utilized the 26.4-pound (12.0 kg) Magnetically Anchored Gravity Systems (MACS), which consisted of two identical subsystem packages, each containing an extensible rod unit and a magnetically anchored spherical viscous damper. The rod units had an extended length of 15.8 meters (52 ft), and their 5-kilogram (11 lb) damper tip weights gave the satellite a symmetric dumbbell configuration. The dampers were produced by General Electric and consisted of two concentric spheres separated by a viscous damping fluid. The internal sphere contained a hollow cylindrical magnet which served to "anchor' the inner sphere to the Earth's magnetic field, stabilizing the satellite over time. It had been hoped that within 60 days of launch, the satellite would reach a stabilization of ±8° on the x- and y-axis. The results were compromised, as one of the dampers was magnetically contaminated. A follow-up GGTS mission was lost due to a launch vehicle failure on August 28, 1966.
Anthrax is an infection caused by the bacterium Bacillus anthracis or Bacillus cereus biovar anthracis. Infection typically occurs by contact with the skin, inhalation, or intestinal absorption. Symptom onset occurs between one day and two months after the infection is contracted. The skin form presents with a small blister with surrounding swelling that often turns into a painless ulcer with a black center. The inhalation form presents with fever, chest pain, and shortness of breath. The intestinal form presents with diarrhea (which may contain blood), abdominal pains, nausea, and vomiting. According to the U.S. Centers for Disease Control and Prevention, the first clinical descriptions of cutaneous anthrax were given by Maret in 1752 and Fournier in 1769. Before that, anthrax had been described only in historical accounts. The German scientist Robert Koch was the first to identify Bacillus anthracis as the bacterium that causes anthrax. Anthrax is spread by contact with the bacterium's spores, which often appear in infected animal products. Contact includes inhalation, eating, or through an area of broken skin. It does not typically spread directly between people. At risk populations include people who work with animals or animal products and military personnel. Diagnosis can be confirmed by finding antibodies or the toxin in the blood or by the culture of a sample from the infected site. The anthrax vaccine is recommended for people at high risk of infection. Immunizing animals against anthrax is recommended in areas where previous infections have occurred. A two-month course of antibiotics such as ciprofloxacin, levofloxacin and doxycycline after exposure can also prevent infection. If infection occurs, treatment is with antibiotics and possibly antitoxin. The type and number of antibiotics used depend on the type of infection. An antitoxin is recommended for those with widespread infection. A rare disease, human anthrax is most common in Africa and central and southern Asia. It occurs more regularly in Southern Europe than elsewhere on the continent and is uncommon in Northern Europe and North America. Globally, at least 2,000 cases occur a year, with about two cases a year in the United States. Skin infections represent more than 95% of cases. Without treatment the risk of death from skin anthrax is 23.7%. For intestinal infection the risk of death is 25 to 75%, while respiratory anthrax has a mortality of 50 to 80%, even with treatment. Until the 20th century, anthrax infections killed hundreds of thousands of people and animals each year. In herbivorous animals, infection occurs when they eat or breathe in the spores while grazing. Humans may become infected by killing and/or eating infected animals. Several countries and non-state groups have developed anthrax as a weapon. It has been used in biowarfare and bioterrorism since 1916. Likely delivery methods of weaponized anthrax include aerial dispersal or dispersal through livestock. In World War II, it was developed and used by the Empire of Japan's Unit 731 against China, and researched by a British plan against Nazi Germany. The Soviet, United States, and Iraqi biological weapons program developed weaponized strains. In 1975, the Biological Weapons Convention prohibited the "development, production and stockpiling" of biological weapons. It has since been used in bioterrorism, including the 2001 anthrax attacks in the United States and an incident in 1993 by the Aum Shinrikyo group in Japan.
Kava or kava kava (Piper methysticum: Latin 'pepper' and Latinized Greek 'intoxicating') is a plant in the pepper family, native to the Pacific Islands. The name kava is from Tongan and Marquesan, meaning 'bitter'. Kava can refer to either the plant or a psychoactive beverage made from its root. The beverage is a traditional ceremonial and recreational drink from Polynesia, Micronesia, and Melanesia. Nakamals and kava bars exist in many countries. Traditional kava is made by grinding fresh or dried kava root, mixing it with water or coconut milk, and straining it into a communal bowl. Outside the South Pacific, kava is typically prepared by soaking dried root powder in water and straining it. It is consumed socially for its psychoactive effects, comparable to those produced by alcohol but without significant cognitive impairment or addiction risk. Kava also produces a numbing sensation in the mouth. Kava consists of sterile cultivars clonally propagated from its wild ancestor, Piper wichmanii. It originated in northern Vanuatu, where it was domesticated by farmers around 3,000 years ago through selective cultivation. Historically, the beverage was made from fresh kava; preparation from dry kava emerged in response to the efforts of Christian missionaries in the 18th and 19th centuries to prohibit the drinking of kava. According to in vitro research, the pharmacological effects of kava stem primarily from six major kavalactones that modulate GABAA, dopamine, norepinephrine, and CB1 receptors, and inhibit MAO-B and ion channel mechanisms. Kava reduces short-term, situational anxiety, but its specific efficacy for generalized anxiety disorder appears to not be supported by the evidence. Many countries banned or restricted kava in 2002 due to safety concerns. The World Health Organization (WHO) subsequently reviewed kava's safety and concluded that moderate consumption of kava in its traditional form, as a water-based suspension of roots, presents an "acceptably low level of health risk". However, WHO and other health authorities have also concluded that consumption of kava extracts produced with organic solvents or excessive amounts of low-quality kava products may be linked to an increased risk of adverse health outcomes, including liver injury.
Jaundice, also known as icterus, is a yellowish or, less frequently, greenish pigmentation of the skin and conjunctivae due to high bilirubin levels. Jaundice in adults typically indicates the presence of underlying diseases involving abnormal heme metabolism, liver dysfunction, or biliary-tract obstruction. The prevalence of jaundice in adults is rare, while jaundice in babies is common, with an estimated 80% affected during their first week of life. The most commonly associated symptoms of jaundice are itchiness, pale feces, and dark urine. Normal levels of bilirubin in blood are below 1.0 mg/dl (17 μmol/L), while levels over 2–3 mg/dl (34–51 μmol/L) typically result in jaundice. High blood bilirubin is divided into two types: unconjugated and conjugated bilirubin. Causes of jaundice vary from relatively benign to potentially fatal. High unconjugated bilirubin may be due to excess red blood cell breakdown, large bruises, genetic conditions such as Gilbert's syndrome, not eating for a prolonged period of time, newborn jaundice, or thyroid problems. High conjugated bilirubin may be due to liver diseases such as cirrhosis or hepatitis, infections, medications, or blockage of the bile duct, due to factors including gallstones, cancer, or pancreatitis. Other conditions can also cause yellowish skin, but are not jaundice, including carotenemia, which can develop from eating large amounts of foods containing carotene—or medications such as rifampin. Treatment of jaundice is typically determined by the underlying cause. If a bile duct blockage is present, surgery is typically required; otherwise, management is medical. Medical management may involve treating infectious causes and stopping medication that could be contributing to the jaundice. Jaundice in newborns may be treated with phototherapy or exchanged transfusion depending on age and prematurity when the bilirubin is greater than 4–21 mg/dl (68–365 μmol/L). The itchiness may be helped by draining the gallbladder, ursodeoxycholic acid, or opioid antagonists such as naltrexone. The word jaundice is from the French jaunisse, meaning 'yellow disease'.
Before the 1921 destruction of Tulsa’s Greenwood District, Black residents had created a remarkable center of business and community life. The district included stores, professional offices, entertainment venues and homes owned by Black citizens. Understanding Greenwood means learning what was built—not only what was burned.
MORE →Madam C.J. Walker